Document Detail

Comparison of serious adverse reactions between thalidomide and lenalidomide: analysis in the French Pharmacovigilance database.
MedLine Citation:
PMID:  24078083     Owner:  NLM     Status:  Publisher    
Thalidomide and lenalidomide are structural analogs and immunomodulatory drugs. Lenalidomide appears to have a different safety profile than thalidomide and could be less toxic, and as far as we know, we did not found any study comparing their safety profile. The objective of our study was to review and compare serious adverse drug reactions (SADRs) of thalidomide and lenalidomide spontaneously reported to the French Pharmacovigilance database. We extracted all medically confirmed spontaneous reports of SADR for lenalidomide-based regimens and thalidomide-based regimens from the French Pharmacovigilance database. A "serious" adverse drug reaction (ADR) was defined as an ADR that is fatal or life threatening, which causes hospitalization or prolongation of hospitalization, or permanent or significant disability. The study period was between marketing of 2 drugs and January 15, 2012. A total of 392 SADRs related to thalidomide-based regimens were identified in 244 patients and 377 SADRs related to lenalidomide-based regimens in 220 patients. In spite of their structural analogy, this study highlights interesting differences between lenalidomide and thalidomide's safety profile: nervous system and vascular disorders are more frequent with thalidomide-based regimens while hematologic, skin, infectious disorders and secondary primary cancers are more frequent with lenalidomide-based regimens.
Pascale Olivier-Abbal; Anne-Charlotte Teisseyre; Jean-Louis Montastruc;
Related Documents :
23816673 - New orally active anticoagulants in critical care and anesthesia practice: the good, th...
24940523 - Prevalence of substance misuse in new patients in an outpatient psychiatry clinic using...
25152793 - Drugs with narrow therapeutic index as indicators in the risk management of hospitalise...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-9-28
Journal Detail:
Title:  Medical oncology (Northwood, London, England)     Volume:  30     ISSN:  1559-131X     ISO Abbreviation:  Med. Oncol.     Publication Date:  2013 Dec 
Date Detail:
Created Date:  2013-9-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9435512     Medline TA:  Med Oncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  733     Citation Subset:  -    
Laboratoire de Pharmacologie Médicale et Clinique, UMR-INSERM U1027, Equipe de Pharmacoépidémiologie, Faculté de Médecine, Université de Toulouse, 37 allées Jules Guesdes, 31000, Toulouse, France,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Nutrient resorption of two evergreen shrubs in response to long-term fertilization in a bog.
Next Document:  The enzyme engineering of mutant homodimer and heterodimer of coproporphyinogen oxidase contributes ...